Infant mortality rates regressed against number of vaccine doses routinely given: is there a biochemical or synergistic toxicity?
http://het.sagepub.com/content/30/9/1420.long
http://het.sagepub.com/content/30/9/1420.long
Miller NZ, Goldman GS. Hum Exp Toxicol. 2011 Sep;30(9):1420-8.
"The infant mortality rate (IMR) is one of the most important indicators of the socio-economic well-being and public health conditions of a country. The US childhood immunization schedule specifies 26 vaccine doses for infants aged less than 1 year--the most in the world--yet 33 nations have lower IMRs. Using linear regression, the immunization schedules of these 34 nations were examined and a correlation coefficient of r = 0.70 (p < 0.0001) was found between IMRs and the number of vaccine doses routinely given to infants. Nations were also grouped into five different vaccine dose ranges: 12-14, 15-17, 18-20, 21-23, and 24-26. The mean IMRs of all nations within each group were then calculated. Linear regression analysis of unweighted mean IMRs showed a high statistically significant correlation between increasing number of vaccine doses and increasing infant mortality rates, with r = 0.992 (p = 0.0009). Using the Tukey-Kramer test, statistically significant differences in mean IMRs were found between nations giving 12-14 vaccine doses and those giving 21-23, and 24-26 doses. A closer inspection of correlations between vaccine doses, biochemical or synergistic toxicity, and IMRs is essential."
____________________________________________________________
CHE WORKING GROUP LISTSERV INSTRUCTIONS
Just click the link for the action you want to perform and hit "send" on the resulting email.
Please remove me from this working group (including email list):
chescience-unsubscribe@lists.healthandenvironment.org
Switch my subscription mode to CHE Lite (receive one digest email per weekday):
mailto:sympa@lists.healthandenvironment.org?body=SET%20chescience%20DIGEST
Keep me as part of this group, but stop sending me emails (this is useful for vacations):
mailto:sympa@lists.healthandenvironment.org?body=SET%20chescience%20NOMAIL
Access the listserv website (to view archives, update your email address, change your subscription
preference, etc.):
http://lists.healthandenvironment.org/lists/info/chescience
Ask a question or get more help
mailto:info@healthandenvironment.org?subject=chesciencequestion
Please remember that CHE Working Group correspondence may only be forwarded or posted elsewhere if all personal commentary has been removed from the original post. To forward personal commentary explicit permission of the author must first be obtained.
Information posted to this listserv does not necessarily reflect the views or opinions of CHE or the sender. CHE aims to distribute science from a variety of perspectives which may be of interest to the CHE community.
